You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Detecting Substandard, Nonconforming, Improperly Processed and Counterfeit Materiel
SBC: Ocean Bay Information and Systems Management, LLC Topic: DLA15C001"Micro-calorimetry is a Nondestructive Test (NDT) capable of detecting heat characteristics that could identify improperly processed, counterfeit, substandard, nonconforming or fake raw material prior to materials introduction into end-product production cycles. Current calorimetric technology is an extremely sensitive, expensive and time consuming process, utilizing an adiabatic or semi-adiabat ...
STTR Phase I 2016 Department of DefenseDefense Logistics Agency -
Marburg Virus Prophylactic Medical Countermeasure
SBC: MAPP BIOPHARMACEUTICAL, INC. Topic: CBD18A002There are currently no vaccines or therapeutics available for Marburg Virus Disease (MVD). Given the specter of weaponization and the terriblemorbidity and high mortality rate of MVD, this represents a critical threat to the operational readiness of the Warfighter. While traditionalvaccines have proven to be a huge contribution to public health, they do have some limitations especially in the cont ...
STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense -
Marburg Virus Prophylactic Medical Countermeasure
SBC: Flow Pharma, Inc. Topic: CBD18A002Flow Pharma, Inc. is a biotechnology company in the San Francisco Bay Area developing fully synthetic cytotoxic T lymphocyte (CTL)stimulating peptide vaccines for Marburg virus. The FlowVax vaccine platform allows us to create dry powder formulations of biodegradablemicrospheres and TLR adjuvants incorporating class I and class II T cell epitopes. FlowVax vaccines can be designed for delivery by i ...
STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense -
STTR Phase I: A Closed Loop Process for the recycle of End-of-Life Li-ion Batteries
SBC: Battery Resourcers LLC Topic: CTThe broader impact/commercial potential of this Small Business Technology Transfer Phase I project is to improve the recycling rates and efficiency of lithium ion (Li-ion) batteries, as well as lower the cost of cathode materials for Li-ion batteries. This research project will accomplish these goals by recovering cathode material from a broad spectrum of Li-ion battery regardless of size, shape o ...
STTR Phase I 2016 National Science Foundation -
STTR Phase I: Advanced Computational System for Assessing Genetic Provenance in Crop Plants and its Practical Applications
SBC: Prosapia Genetics LLC Topic: BTThe broader impact/commercial potential of this Small Business Technology Transfer (STTR) project will be the development of a highly accurate genotype analysis technique and the computational pipeline for assessing genetic provenance in crop plants. The commercial potential of the proposed products and services is based on the need to increase crop yield and accelerate breeding programs. The prop ...
STTR Phase I 2016 National Science Foundation -
STTR Phase I: Advanced Thermophotovoltaic Generators for High-Value Remote Power
SBC: Marigold Power, Inc. Topic: PHThe broader impact / commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to enable electrification of remote oil & gas processes to reduce methane emissions, improve on-site safety, and provide leak-detection and monitoring capabilities. This will be achieved by developing a robust, efficient, small-scale power generator capable of converting on-site fuel to e ...
STTR Phase I 2018 National Science Foundation -
STTR Phase I: Affinity Chromatographic Cell Sorting (AFFICS) System for Simultaneous Multiple Cell Separation
SBC: QT HOLDING CORP Topic: BTThe broader impact/commercial potential of this Small Business Technology Transfer (STTR) project will be the development of a cell sorting system to allow separation of two or more cell types to be used in cell therapies for treatment of cancer and other diseases. Purification of specific cell populations from complex materials such as blood is a critical component of cell therapy manufacturing. ...
STTR Phase I 2016 National Science Foundation -
STTR Phase I: A Mobile Triage Application for Reducing the Risk of COPD Exacerbations
SBC: REVON SYSTEMS, INC Topic: SHThe broader impact/commercial potential of this Small Business Technology Transfer (STTR) project is the reduction of significant disease flare-ups in patients with Chronic Obstructive Pulmonary Disease (COPD), increase in patient quality-of-life, and a reduction of expensive and unnecessary healthcare utilization. Current at-home care support for COPD patients is often completely missing or consi ...
STTR Phase I 2018 National Science Foundation -
STTR Phase I: An integrated platform for the analysis of patient health record data to enable predictive clinical decision support
SBC: Dascena, Inc. Topic: SHThe broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to reduce preventable patient readmissions, streamline triage, and detect multi-organ diseases early. Currently, failures of care delivery and care coordination, overtreatment, and administrative complexity cost the American healthcare system an estimated 300 billion dollars per year, and a ...
STTR Phase I 2016 National Science Foundation -
STTR Phase I: An On-Demand Protein Engineering Platform
SBC: SYNVITROBIO, INC. Topic: BTThe broader impact/commercial potential of this Small Business Technology Transfer (STTR) project will be the development of a platform technology for high-throughput protein expression. The current standard for expressing panels of proteins involves extensive bioinformatics, cloning, in vivo expression, and assays. This method takes significant expertise in disparate fields, and weeks to months o ...
STTR Phase I 2016 National Science Foundation